Treatment strategies for oligometastatic and oligorecurrent epithelial ovarian cancer: a narrative review. [PDF]
Viveros-Carreño D +8 more
europepmc +1 more source
Radiotherapy and Immunotherapy at a Crossroads: Mechanistic Foundations, Emerging Evidence, and a New Horizon for Precision Oncology. [PDF]
Ferini G, Forte S.
europepmc +1 more source
Utilising Radiotherapy in Managing Oligoprogression in Metastatic Melanoma
A. Hlodáková +7 more
openaire +1 more source
Patterns of failure in metastatic ALK-positive NSCLC treated with crizotinib: implications for consolidative stereotactic body radiotherapy. [PDF]
Wang Z +7 more
europepmc +1 more source
Acquired TPM3::NTRK1 fusion as a novel off-target resistance mechanism to selpercatinib in RET-positive lung adenocarcinoma: a case report. [PDF]
Choudhury R +6 more
europepmc +1 more source
Rethinking Immunotherapy Resistance in Melanoma: A Narrative Review of Clinical Patterns, Resistance Mechanisms, and Future Strategies. [PDF]
Ghais A +12 more
europepmc +1 more source
Case Report: MR-guided adaptive stereotactic body radiotherapy for splenic metastases: a case series of technical feasibility and early clinical outcomes. [PDF]
Tan D +8 more
europepmc +1 more source
Radiotherapy improves outcomes in patients with NSCLC receiving nivolumab. [PDF]
Saray S +5 more
europepmc +1 more source
Maximizing survival benefit with precision therapy based on progressive patterns after immunochemotherapy in metastatic esophageal cancer. [PDF]
Liu Y +6 more
europepmc +1 more source
Oligoprogression in NSCLC with Other Actionable Oncogenic Drivers Beyond EGFR and ALK: An Emerging Entity. [PDF]
Scaglione IM +10 more
europepmc +1 more source

